Comparing ITC Results From Lenvatinib Plus Everolimus For Second-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- Crossover Versus No Crossover

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.106
https://www.valueinhealthjournal.com/article/S1098-3015(17)30440-0/fulltext
Title : Comparing ITC Results From Lenvatinib Plus Everolimus For Second-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- Crossover Versus No Crossover
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30440-0&doi=10.1016/j.jval.2017.08.106
First page : A415
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 87
Categories :
Tags :
Regions :
ViH Article Tags :